Early studies suggest that this peptide – a dual agonist of GLP-1 and glucose-dependent insulinotropic polypeptide receptors – may provide a substantial improvement in weight reduction programs . Unlike existing medications , the peptide shows to affect appetite and energy expenditure via multiple routes. While further copyrightination is requ